Skip to main content
BMJ Open Access logoLink to BMJ Open Access
letter
. 2023 Nov 28;100(3):188. doi: 10.1136/sextrans-2023-055938

Childhood sexual abuse, risk behaviours and chemsex engagement among men who have sex with men in Paris, France

Marc Shelly 1,2,, Solène Bost 1, David Moreau 1
PMCID: PMC11041584  PMID: 38050175

Drückler et al suggest that chemsex engagement among men who have sex with men (MSM) is significantly associated with reporting non-consensual sex.1 Inspired by clinical stories gathered in a sexual healthcare service, we investigated a possible relationship between childhood sexual abuse (CSA), that is, having been a victim of forced genital contact by an adult before age 13, and current chemsex engagement. To our knowledge, only one recent study reports a ‘higher frequency’ of early sexual abuse—but without specification of type and age of sexual abuse—among adult chemsex-users MSM.2

These data were collected during youth festivals using a computerised, anonymous, self-administered survey of a non-selected population of 225 MSM (median age=23, aged 16–39) living mainly in the Paris area.

After adjustment for potential confounding factors, those who had experienced CSA were more likely than the other MSM to report not having a regular partner (adjusted OR=3.06 (95% CI 1.16 to 8.08, p<0.05)), less likely to protect themselves with a new partner of unknown risk (aOR=0.2 (0.06 to 0. 62), p<0.01), were more likely to be chronic users of both illicit psychoactive substances (aOR=4.91 (2.18 to 11.0), p<0.01) and psychotropic drugs (aOR=3.89 (1.78 to 8.50), p<0.01) and were more likely to be chemsex-users (aOR=5.62 (1.83 to 17.2), p<0.01).

This exploratory study suggests that CSA may be a strong vulnerability factor (nearly six times more likely) predisposing MSM to chemsex engagement. If confirmed by larger studies, these findings should encourage clinicians to systematically ask for a history of CSA in cases of chemsex engagement among MSM and, if deemed necessary, to integrate this major trauma into the overall clinical management of chemsex in a broad risk-harm reduction perspective.

Footnotes

Handling editor: Anna Maria Geretti

Contributors: MS designed this study, SB conducted the fieldwork and collected the data and DM performed the analysis.MS, DM and SB all contributed to the final manuscript.

Funding: The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

Competing interests: None declared.

Provenance and peer review: Not commissioned; internally peer reviewed.

Ethics statements

Patient consent for publication

Not applicable.

Ethics approval

Data were obtained from computerised self-administered questionnaires and were completely anonymous, with the authorisation from the French National Data Protection Authority (CNIL approval n° 00 13 47). Participants gave informed consent to participate in the study before taking part.

References

  • 1. Drückler S, Speulman J, van Rooijen M, et al. Sexual consent and chemsex: a quantitative study on sexualised drug use and non-consensual sex among men who have sex with men in Amsterdam, the Netherlands. Sex Transm Infect 2021;97:268–75. 10.1136/sextrans-2020-054840 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. González-Baeza A, Barrio-Fernández P, Curto-Ramos J, et al. Understanding attachment, emotional regulation, and childhood adversity and their link to chemsex. Subst Use Misuse 2023;58:94–102. 10.1080/10826084.2022.2148482 [DOI] [PubMed] [Google Scholar]

Articles from Sexually Transmitted Infections are provided here courtesy of BMJ Publishing Group

RESOURCES